ZA812085B - Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives - Google Patents

Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives

Info

Publication number
ZA812085B
ZA812085B ZA00812085A ZA812085A ZA812085B ZA 812085 B ZA812085 B ZA 812085B ZA 00812085 A ZA00812085 A ZA 00812085A ZA 812085 A ZA812085 A ZA 812085A ZA 812085 B ZA812085 B ZA 812085B
Authority
ZA
South Africa
Prior art keywords
piperidinylalkyl
pyrido
pyrimidin
novel
4one
Prior art date
Application number
ZA00812085A
Other languages
English (en)
Inventor
L Kennis
J Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA812085B publication Critical patent/ZA812085B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA00812085A 1980-03-28 1981-03-27 Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives ZA812085B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (1)

Publication Number Publication Date
ZA812085B true ZA812085B (en) 1982-11-24

Family

ID=22465278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00812085A ZA812085B (en) 1980-03-28 1981-03-27 Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives

Country Status (5)

Country Link
JP (1) JPS56150091A (enExample)
KR (2) KR850000412B1 (enExample)
PL (2) PL131162B1 (enExample)
SU (1) SU1093251A3 (enExample)
ZA (1) ZA812085B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
DE68926473T2 (de) * 1988-03-28 1996-10-02 Janssen Pharmaceutica Nv Mittel zur Konservierung oder Wiederherstellung der gesunden Haut
DK3106166T3 (da) * 2008-02-29 2021-01-11 Vm Therapeutics Llc Forbindelser til behandling af smertesyndrom og andre lidelser
PL2812004T3 (pl) 2012-02-10 2019-01-31 Ptc Therapeutics, Inc. Związki do leczenia rdzeniowego zaniku mięśni
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
CN113750101A (zh) 2015-12-10 2021-12-07 Ptc医疗公司 用于治疗亨廷顿病的方法
EA201991309A1 (ru) 2016-11-28 2019-11-29 Способы модуляции сплайсинга рнк
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
CN111372611A (zh) 2017-06-14 2020-07-03 Ptc医疗公司 修饰rna剪接的方法
EP3645121B8 (en) 2017-06-28 2025-06-18 PTC Therapeutics, Inc. Methods for treating huntington's disease
CA3067591A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
KR20210005559A (ko) 2018-03-27 2021-01-14 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
LT3814357T (lt) 2018-06-27 2024-06-25 Ptc Therapeutics, Inc. Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
WO2020005877A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease

Also Published As

Publication number Publication date
JPH0215550B2 (enExample) 1990-04-12
PL132428B1 (en) 1985-03-30
PL131162B1 (en) 1984-10-31
JPS56150091A (en) 1981-11-20
KR830005220A (ko) 1983-08-03
PL230364A1 (enExample) 1982-03-29
KR850000413B1 (ko) 1985-03-26
SU1093251A3 (ru) 1984-05-15
KR850000412B1 (ko) 1985-03-26
PL233902A1 (enExample) 1982-07-19

Similar Documents

Publication Publication Date Title
PT72740A (en) Novel 3-(1-piperidinylalkyl)-4h-pyrido/1,2-a/-pyrimidin-4-one derivatives
AU540840B2 (en) Imidazo(1,2-a)pyridines
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
AU531348B2 (en) 1,8 naphthyridine derivatives
ZA812085B (en) Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives
AU7600481A (en) Imidazo (4,5-b)pyridines
AU515352B2 (en) 1, 2-DIHYDRO-3H-PYRROLE (1, 2-a)-PYRROLE-1-NITRILES
GB2098203B (en) Novel 4,5-diaryl-thiazole-2-thiol derivatives
NZ194529A (en) 9,10-dihydro-1h, 4h-pyrazolo (4,3-b)(1,5)benzodiazepin-10-ones
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
AU7338081A (en) 1,2,4-triazolylpropenol derivatives
NZ195248A (en) 4-(piperaz-1-yl)-2,10-dihydropyrazolo (3,4-b)(1,5)-benzodiazepines
CS528780A2 (en) Zpusob vyroby substituovanych pyrido-(1,2-a)pyrimidinu
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
JPS5732239A (en) 2,3-bis-hydroxybenzyl derivative
NZ197563A (en) 3-(1,2,4-triazinylthiomethyl)-3-cephem-1-sulphoxide derivatives
IL61535A0 (en) 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carboxamides
GB2092130B (en) 4-oximino-1,2,3,4-tetrahydroquinoline derivatives
AU521104B2 (en) (1,3-thiazino) (3,4-b)-isoquinolines
GB2080794B (en) 1,6-naphthyridine derivatives
PH14888A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative
GB2013678B (en) 1,4 benzoazine derivatives
AU7744681A (en) 2,3-dihydro-4-pyrone derivatives
NZ192622A (en) 4,7-phenanthroline derivatives
AU542710B2 (en) 16-amino-17-phenyl-18,19,20-trinor-prosta-glandin derivatives